EMILY CORNELIUS: Open Payments
NPI 1437608288 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$906 in 45 payments from 21 companies in 2025. Trend: 2023 $1,740 · 2024 $1,024 · 2025 $906
Food & beverage: $906
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $130 |
| PFIZER INC. | 3 | $104 |
| Janssen Biotech, Inc. | 5 | $90 |
| Regeneron Healthcare Solutions, Inc. | 4 | $85 |
| Novartis Pharmaceuticals Corporation | 5 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $61 |
| SOBI, INC | 2 | $39 |
| TerSera Therapeutics LLC | 1 | $36 |
| Eisai Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 2 | $30 |
Products named: XYNTHA, DATROWAY, LIBTAYO, ERLEADA, Fabhalta, Enhertu, Doptelet, Zoladex.
Industry payments across AL — which companies pay providers there.
